CG Oncology, Inc. (CGON)
CGONNASDAQ-GSBiotechnology: Biological Products (No Diagnostic Substances)
$74.50
+1.62 (+2.22%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $6.49bn
- P/E
- –
- EPS, last 4 quarters
- $-2.76
- Dividend yield
- –
- Day range
- –
- 52-week range
- $35.80 to $80.97
- Average volume
- 993.8k
- Previous close
- $72.88
Analysts
9 coveringBuy9 buy, 0 hold, 0 sell
Targets a year out average $88.71, +19.1% from here
Earnings
next estimate $-0.7600Next report
Dec 2025
+16.4%
Mar 2026
-22.4%
Jun 2026
-28.6%
Sep 2026
+25.6%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $2.32m | $1.08m | $1.16m | $1.60m |
| Gross profit | -$748.0k | -$1.88m | -$2.77m | -$1.06m |
| Operating income | -$48.70m | -$66.39m | -$86.40m | -$63.25m |
| Net income | -$41.31m | -$60.20m | -$79.06m | -$56.89m |
Last four quarters: revenue $6.17m, margin -3851.1%, free cash flow -$189.17m
News
8 latest- Notable Friday Option Activity: SLS, OMDA, CGONBNK Invest · 4 days ago
- CG Oncology, Inc. Reports Third Quarter 2026 Financial ResultsFintel · 4 days ago
- CG Oncology, Inc. (CGON) Reports Q3 Loss, Beats Revenue EstimatesZacks · 5 days ago
- CG Oncology, Inc. Q3 Loss Increases RTTNews · 5 days ago
- Notable Monday Option Activity: GE, CGON, BEBNK Invest · Oct 19, 2026
- Notable Tuesday Option Activity: ASTS, ILPT, CGONBNK Invest · Sep 22, 2026
- CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue EstimatesZacks · Aug 6, 2026
- 5 Stocks That Created Fortunes: CMPS +327%, ARWR +222%, CGON +148%, DRTS +182%, ELMD +86% RTTNews · Jul 27, 2026
The company
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- cgoncology.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.